Kurs
-2,55%
Kurs
-2,55%
Open
15,70
High
15,90
Low
14,80
Close
15,30
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Tid* | ||
2025-02-12 | 09:00 | Bokslutskommuniké 2024 |
2024-11-13 | - | Extra Bolagsstämma 2024 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-07-01 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2024-06-28 | - | Årsstämma |
2024-06-14 | - | Bokslutskommuniké 2023 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-06-12 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2023-06-09 | - | Årsstämma |
2023-04-28 | - | Bokslutskommuniké 2022 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2022-06-09 | - | Årsstämma |
2022-04-29 | - | Bokslutskommuniké 2021 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2021-06-09 | - | Årsstämma |
2021-04-30 | - | Bokslutskommuniké 2020 |
2020-09-11 | - | Extra Bolagsstämma 2020 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-06-11 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2020-06-10 | - | Årsstämma |
2020-04-15 | - | Bokslutskommuniké 2019 |
2019-08-28 | - | Kvartalsrapport 2019-Q2 |
2019-06-06 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2019-06-05 | - | Årsstämma |
2019-04-24 | - | Bokslutskommuniké 2018 |
2019-01-07 | - | Extra Bolagsstämma 2019 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-05-30 | - | Årsstämma |
2018-02-21 | - | Bokslutskommuniké 2017 |
2017-08-16 | - | Kvartalsrapport 2017-Q2 |
2017-06-08 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2017-06-07 | - | Årsstämma |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-11-18 | - | X-dag bonusutdelning ABTEC 1 |
2016-11-17 | - | Extra Bolagsstämma 2016 |
2016-11-17 | - | 15-10 2016-Q3 |
2016-08-17 | - | Kvartalsrapport 2016-Q2 |
2016-06-09 | - | X-dag ordinarie utdelning ABTEC 1.50 NOK |
2016-06-08 | - | Årsstämma |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-11-18 | - | Kvartalsrapport 2015-Q3 |
2015-08-19 | - | Kvartalsrapport 2015-Q2 |
2015-06-04 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2015-06-03 | - | Årsstämma |
2015-05-13 | - | Kvartalsrapport 2015-Q1 |
2015-02-11 | - | Bokslutskommuniké 2014 |
2014-11-26 | - | Kvartalsrapport 2014-Q3 |
2014-08-20 | - | Kvartalsrapport 2014-Q2 |
2014-06-11 | - | Årsstämma |
2014-05-21 | - | Kvartalsrapport 2014-Q1 |
2014-02-12 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-21 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | Kapitalmarknadsdag 2013 |
2013-06-12 | - | X-dag ordinarie utdelning |
2013-06-11 | - | Årsstämma |
2013-05-22 | - | Kvartalsrapport 2013-Q1 |
2013-02-13 | - | Bokslutskommuniké 2012 |
2012-11-27 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-17 | - | Bokslutskommuniké 2011 |
2011-11-30 | - | Kvartalsrapport 2011-Q3 |
2011-08-29 | - | Kvartalsrapport 2011-Q2 |
2011-06-17 | - | X-dag ordinarie utdelning |
2011-06-16 | - | Årsstämma |
2011-05-30 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-06-14 12:42:03
14.6.2021 12:42:01 CEST | Aqua Bio Technology ASA | Mandatory notification of
trade primary insiders
Reference is made to the stock exchange notice from Aqua Bio Technology ASA (the
"Company") on 15 April 2021 regarding completion of a private placement raising
gross proceeds of approximately NOK 15 million through issuance 1,303,707 new
shares (the "Private Placement") and the share lending agreement entered into
between the Company and shareholder Kjeveortoped Espen Dahl AS.
All of the 605,017 borrowed shares have today been returned to Kjeveortoped
Espen Dahl AS. Kjeveortoped Espen Dahl AS is a close associate of board member
Kristin Aase.
Please see the attached form for further information.
* * *
For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092.
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is such that Aqua Bio Technology ASA is required to disclose in
accordance with the EU Market Abuse Regulation, and is subject to the disclosure
requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
ATTACHMENTS
Notification form Kjeveortoped Espen Dahl AS Redelivery of shares.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/643/855/Notification%20form%20Kje
veortoped%20Espen%20Dahl%20AS%20Redelivery%20of%20shares.pdf